111 related articles for article (PubMed ID: 8222725)
1. The platelet-activating factor precursor of the injured cornea is selectively implicated in arachidonate and eicosanoid release.
Hurst JS; Bazan HE
Curr Eye Res; 1993 Jul; 12(7):655-63. PubMed ID: 8222725
[TBL] [Abstract][Full Text] [Related]
2. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor preferentially stimulates the phospholipase A2/cyclooxygenase cascade in the rabbit cornea.
Hurst JS; Bazan HE
Curr Eye Res; 1995 Sep; 14(9):769-75. PubMed ID: 8529415
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of arachidonate and paf-acether precursor pools in mast cells.
Joly F; Breton M; Wolf C; Ninio E; Colard O
Biochim Biophys Acta; 1992 May; 1125(3):305-12. PubMed ID: 1596519
[TBL] [Abstract][Full Text] [Related]
5. Differences in the acyl composition of the platelet-activating factor (PAF) precursor and other choline phosphoglycerides of the rabbit retinal rod outer segments and neural retina.
Bazan HE; Hurst JS; Bazan NG
Curr Eye Res; 1994 Jan; 13(1):45-50. PubMed ID: 8156825
[TBL] [Abstract][Full Text] [Related]
6. Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages.
Albert DH; Snyder F
Biochim Biophys Acta; 1984 Oct; 796(1):92-101. PubMed ID: 6435681
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product.
Malone B; Lee T; Snyder F
J Biol Chem; 1985 Feb; 260(3):1531-4. PubMed ID: 3918041
[TBL] [Abstract][Full Text] [Related]
8. CD2 triggering stimulates the formation of platelet-activating factor-acether from alkyl-arachidonoyl-glycerophosphocholine in a human CD4+ T lymphocyte clone.
Le Gouvello S; Vivier E; Debre P; Thomas Y; Colard O
J Immunol; 1992 Aug; 149(4):1289-93. PubMed ID: 1354232
[TBL] [Abstract][Full Text] [Related]
9. Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonists.
Yousufzai SY; Abdel-Latif AA
Biochem J; 1985 Jun; 228(3):697-706. PubMed ID: 3927898
[TBL] [Abstract][Full Text] [Related]
10. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products.
Bazan HE; Reddy ST; Woodland JM; Bazan NG
Biochem Biophys Res Commun; 1987 Dec; 149(3):915-20. PubMed ID: 2827658
[TBL] [Abstract][Full Text] [Related]
11. Oxidant and anti-oxidant effects on arachidonate metabolism by rabbit ocular tissues.
Hurst JS; Paterson CA; Short CS
J Ocul Pharmacol; 1989; 5(1):51-64. PubMed ID: 2497216
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of platelet activating factor by ocular tissue from inflamed eyes.
Rosenbaum JT; Boney RS; Samples JR; Valone FH
Arch Ophthalmol; 1991 Mar; 109(3):410-3. PubMed ID: 2003804
[TBL] [Abstract][Full Text] [Related]
13. Esterification of 8,11,14-eicosatrienoate and arachidonate into alkylacyl- and diacylglycerophosphocholine by vascular endothelial cells.
Rosenthal MD; Brown ME; Jones JE
Lipids; 1988 Nov; 23(11):1089-92. PubMed ID: 3148797
[TBL] [Abstract][Full Text] [Related]
14. Arachidonyl transfer from diacyl phosphatidylcholine to ether phospholipids in rat platelets.
Colard O; Breton M; Bereziat G
Biochem J; 1984 Sep; 222(3):657-62. PubMed ID: 6435602
[TBL] [Abstract][Full Text] [Related]
15. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
16. The regulation of CoA-independent transacylation reactions in neuronal nuclei by lysophospholipid, free fatty acid, and lysophospholipase: the control of nuclear lyso platelet-activating factor metabolism.
Baker RR; Chang HY
Mol Cell Biochem; 2000 Dec; 215(1-2):135-44. PubMed ID: 11204449
[TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2.
Kramer RM; Jakubowski JA; Deykin D
Biochim Biophys Acta; 1988 Apr; 959(3):269-79. PubMed ID: 3355850
[TBL] [Abstract][Full Text] [Related]
18. Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18).
Triggiani M; Chilton FH
Biochim Biophys Acta; 1989 Nov; 1006(1):41-51. PubMed ID: 2572273
[TBL] [Abstract][Full Text] [Related]
19. 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a novel source of arachidonic acid in neutrophils stimulated by the calcium ionophore A23187.
Swendsen CL; Ellis JM; Chilton FH; O'Flaherty JT; Wykle RL
Biochem Biophys Res Commun; 1983 May; 113(1):72-9. PubMed ID: 6407484
[TBL] [Abstract][Full Text] [Related]
20. Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell.
Triggiani M; Fonteh AN; Chilton FH
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):497-503. PubMed ID: 1530582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
